Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

11,918 public trials 2,533 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Completed

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

NCT00036556

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Urology Centers Of Alabama Homewood, Alabama, United States
  • Alaska Clinical Research Center, LLC Anchorage, Alaska, United States
  • Advanced Clinical Trials Tucson, Arizona, United States
  • Arkansas Urologial Associates, PA Little Rock, Arkansas, United States
View all 234 locations
View Trial Details
Completed

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

NCT00073125

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Virginia G. Piper Cancer Center Scottsdale, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
  • Clinical Trials and Research Associates Montebello, California, United States
View all 18 locations
View Trial Details
Completed

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

NCT00264433

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +40 more
Locations
  • Florida Cancer Specialist Fort Myers, Florida, United States
  • Lineberger Comprensive Cancer Center Chapel Hill, North Carolina, United States
  • Duke Comprehensive Cancer Centre Durham, North Carolina, United States
  • Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States
View Trial Details
Completed

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

NCT00070837

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Weill Medical College of Cornell University/ New York Presbyterian Hospital New York, United States
  • Duke University Medical Center, Box 3532 Durham, North Carolina, United States
  • Cleveland Clinic, Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

NCT00490711

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bratislava, Slovakia
View Trial Details
Completed

Intravesical Chemotherapy Treatment of Superficial Bladder Cancer

NCT00491114

Conditions
Bladder Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Como, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Genova, Italy
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy
View Trial Details
Completed

Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer

NCT00490880

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland
View Trial Details

Related conditions